| Kathleen Farrell, | |
|
3 Alumni Dr Ste 401, Exeter, NH 03833-2123 | |
| (603) 778-0557 | |
| (603) 778-1669 |
| Full Name | Kathleen Farrell |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 7 Years |
| Location | 3 Alumni Dr Ste 401, Exeter, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356872675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 21657 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Exeter Hospital Inc | Exeter, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Core Physicians Llc | 2769563253 | 234 |
News Archive
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.
The Food and Drug Administration today announced the settlement of a court case against an Illinois firm involved last year in FDA's seizure of thousands of imported unapproved drugs, including those that were labeled in foreign languages and/or labeled as repacked.
The Immune Deficiency Foundation has announced the launch of a mobile app for IDF ePHR, the electronic health record specifically designed for the primary immunodeficiency (PI) community. IDF ePHR allows individuals and caregivers living with PI to track important health information, including medications, diagnoses, symptoms, infections, and other critical data.
Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 8 days ago
| Entity Name | Core Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336330588 PECOS PAC ID: 2769563253 Enrollment ID: O20080123000205 |
News Archive
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.
The Food and Drug Administration today announced the settlement of a court case against an Illinois firm involved last year in FDA's seizure of thousands of imported unapproved drugs, including those that were labeled in foreign languages and/or labeled as repacked.
The Immune Deficiency Foundation has announced the launch of a mobile app for IDF ePHR, the electronic health record specifically designed for the primary immunodeficiency (PI) community. IDF ePHR allows individuals and caregivers living with PI to track important health information, including medications, diagnoses, symptoms, infections, and other critical data.
Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Farrell, 7 Holland Way Fl 1, Exeter, NH 03833-2997 Ph: (603) 778-0557 | Kathleen Farrell, 3 Alumni Dr Ste 401, Exeter, NH 03833-2123 Ph: (603) 778-0557 |
News Archive
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.
The Food and Drug Administration today announced the settlement of a court case against an Illinois firm involved last year in FDA's seizure of thousands of imported unapproved drugs, including those that were labeled in foreign languages and/or labeled as repacked.
The Immune Deficiency Foundation has announced the launch of a mobile app for IDF ePHR, the electronic health record specifically designed for the primary immunodeficiency (PI) community. IDF ePHR allows individuals and caregivers living with PI to track important health information, including medications, diagnoses, symptoms, infections, and other critical data.
Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 8 days ago
Rong Tang, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 301, Exeter, NH 03833 Phone: 603-775-7405 Fax: 603-775-7424 | |
Dr. Maribeth M. Dinicola, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 401, Exeter, NH 03833 Phone: 603-778-0557 Fax: 603-778-1669 | |
Mrs. Evelyne Caron, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr, Suite 401, Exeter, NH 03833 Phone: 603-778-0557 Fax: 603-778-1669 | |
Dr. Deborah S. Browne, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr, Suite 401, Exeter, NH 03833 Phone: 603-778-0557 Fax: 603-778-1669 | |
Emily Travers, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 401, Exeter, NH 03833 Phone: 603-778-0557 Fax: 603-778-1669 | |
Dr. William Herbert Gaw Jr., M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3 Alumni Dr Ste 401, Exeter, NH 03833 Phone: 603-778-0557 Fax: 603-778-1669 |